GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Files For Chapter 11, Says CEO Resigns
2/3/2006 10:47:58 AM
More...
|
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Initiates Additional Prestigious Medical Site For GCS-100 Phase I/II Multiple Myeloma Clinical Trial
11/17/2005 11:55:54 AM
More...
|
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) To Present At The Bio-Europe 2005 Partnering Conference
11/4/2005 1:22:18 PM
More...
|
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Announces $20.0 Million Common Stock Purchase Agreement With Fusion Capital
10/24/2005 11:01:47 AM
More...
|
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Comments On 2004 Year-End Financial Results; Annual Conference Call Scheduled On April 7, 2005
10/19/2005 5:13:14 PM
More...
|
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Initiates Phase I/II Clinical Trial Of GCS-100LE In Multiple Myeloma At Dana-Farber Cancer Institute; Trial Based On Promising Pre-Clinical Data
10/19/2005 5:13:12 PM
More...
|
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Conference Call Alert For April 7, 2005
10/19/2005 5:13:12 PM
More...
|
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) To Make Presentation At Glycomics And Carbohydrates In Drug Development Conference
10/19/2005 5:13:04 PM
More...
|
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Closes On First Of Two Tranches In A $6,500,000 Financing
10/19/2005 5:13:01 PM
More...
|
GlycoGenesys, Inc. (Formerly SafeScience, Inc.) (GLGS) Senior Scientist To Make Presentation At 229th American Chemical Society Meeting
10/19/2005 5:13:01 PM
More...
|
|